B. Tunca Et Al. , "CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer," TUMORI JOURNAL , vol.98, no.2, pp.243-251, 2012
Tunca, B. Et Al. 2012. CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer. TUMORI JOURNAL , vol.98, no.2 , 243-251.
Tunca, B., Egeli, Ü., Çeçener, G., Tezcan, G., Gokgoz, S., Tasdelen, L., ... Bayram Arlı, N.(2012). CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer. TUMORI JOURNAL , vol.98, no.2, 243-251.
Tunca, BERRİN Et Al. "CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer," TUMORI JOURNAL , vol.98, no.2, 243-251, 2012
Tunca, BERRİN Et Al. "CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer." TUMORI JOURNAL , vol.98, no.2, pp.243-251, 2012
Tunca, B. Et Al. (2012) . "CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer." TUMORI JOURNAL , vol.98, no.2, pp.243-251.
@article{article, author={BERRİN TUNCA Et Al. }, title={CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer}, journal={TUMORI JOURNAL}, year=2012, pages={243-251} }